Hila Milo Rasouly Columbia UniversityUnited States

Hila Milo Rasouly is an Assistant Professor of Medical Sciences in the Department of Medicine and the Associate Director of Education of the Center for Precision Medicine and Genomics at Columbia University. She has a master in Genetic Counseling from the Hebrew University in Jerusalem, Israel and a Ph.D. in Genetics and Genomics from Boston University, MA. Her research interests are focused on the implementation of genomics in internal medicine.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	APOL1 Targeted Therapies: Who to Test and Which Disease to Treat? ChairpersonFatiu Abiola Arogundade Obafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria Nigeria ChairpersonFernanda Sales Luiz Vianna fslvianna@gmail.comUniversidade Federal do Rio Grande do SulBrazil ChairpersonOpeyemi Olabisi opeyemi.olabisi@duke.eduDuke University School of MedicineUnited States Ethical Aspects of Race-based Genetic Testing SpeakerAna Iltis iltisas@wfu.eduWake Forest UniversityUnited States Contribution of ApoL1 Risk Genotype to HIVAN SpeakerSaraladevi Naicker University of the Witwatersrand South Africa Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa SpeakerDwomoa Adu dwoms@blueyonder.co.ukUniversity of Ghana Medical SchoolGhana Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials SpeakerOgo Egbuna ogo_egbuna@vrtx.comVertex Pharmaceuticals IncUnited States Q and A Hall C2
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) ChairpersonAgnes Fogo United States ChairpersonGuillermo Rosa Diez guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina My Story SpeakerVictoria Gray vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture SpeakerObiageli Eunice Nnodu oennodu@gmail.comUniversity of AbujaNigeria Hall A
12:15 p.m. 1:15 p.m.	Hot Debate: Should a Low Protein Diet (+/- Ketoanalogue Supplementation) Be Part of Advanced CKD Management? ChairpersonCarla Avesani carla.avesani@ki.seKarolinska InstituteSweden ChairpersonSahir Kalim skalim@mgh.harvard.eduHarvard Medical School/ Massachusetts General Hospital United States Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - PROS SpeakerConnie Rhee crhee@mednet.ucla.eduUCLAUnited States Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - CONS SpeakerSwapnil Hiremath University of OttawaCanada Hall A
3 p.m. 4 p.m.	Kidney Health for All - Advancing Equitable Access to Care and Optimal Medication Practice: WKD Session ChairpersonDina Abdellatif Cairo University HospitalEgypt ChairpersonVassilios Liakopoulos liakopul@otenet.gr2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thesalloniki, GreeceGreece Building Bridges to Reduce Fragmentation of Kidney Care SpeakerRicardo Correa Rotter correarotter@gmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico Transforming Kidney Care Through Equitable Breakthrough Therapies SpeakerKatherine Tuttle University of Washington School of Medicine, Division of NephrologyUnited States Closing the Gaps: Implementing Best Practices for CKD Care Worldwide SpeakerValerie Luyckx valerie.luyckx@uzh.chUniversity of ZurichSwitzerland A Patient's Perspective on Gaps in Care SpeakerMaria Seijas Mseijas@ifc.orgCFAArgentina Q and A Hall C1
4:30 p.m. 5:30 p.m.	Policy and Advocacy Approaches ChairpersonLori-Ann Fisher University of the West Indies, MonaJamaica ChairpersonMarcello Tonelli University of CalgaryCanada Universal Health Coverage for Kidney Diseases: Feasibility, Barriers, and Opportunities for Improving Global Kidney Health SpeakerVivekanand Jha George Institute for Global Health IndiaIndia The Role of Kidney Health Advocacy Organizations in Reducing the Global Burden of Kidney Diseases SpeakerValerie Luyckx valerie.luyckx@uzh.chUniversity of ZurichSwitzerland A Case for National Prevention Programs to Manage CKD SpeakerIkechi Okpechi University of AlbertaCanada Q and A Hall A

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Genetics and Genomics of Rare Kidney Disease: ISN-Indian SN Joint Session ChairpersonPaula Coccia paula.coccia@hospitalitaliano.org.arHospital Italianod de Buenos Aires Argentina ChairpersonShyam Bihari Bansal Department of Nephrology, Medanta-The Medicity, Gurgaon, IndiaIndia Genomics of Rare Genetic Diseases: Experiences From India SpeakerVinod Scaria vinods@igib.inVishwanath Cancer Care Foundation & Indian Institute of Technology KanpurIndia On the Way to Translate GWAS into Kidney Disease Mechanisms SpeakerKrzysztof Kiryluk Columbia UniversityUnited States X-linked Kidney Disorders in Women SpeakerMichelle Rheault rheau002@umn.eduUniversity of MinnesotaUnited States Prenatal/Preimplantation Genetic Diagnosis and Genetic Counseling for Genetic Kidney Disorders SpeakerNine Knoers v.v.a.m.knoers@umcg.nlDepartment of Genetics, University Medical Centre Groningen, Groningen, The NetherlandsNetherlands Q and A Hall E
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) ChairpersonJose Vicente Sanchez Polo visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala ChairpersonMeg Jardine NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Generative AI Revolution in Medicine SpeakerMichal Rosen-Zvi ROSEN@il.ibm.comhttps://research.ibm.com/Israel Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) SpeakerMohammad Shakib Uz Zaman Arefin shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? ChairpersonMarta Adragna marta.adragna@gmail.comArgentina ChairpersonMoumita Barua moumita.barua@uhn.caCanada Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? - All Patients SpeakerAlbertien M. Van Eerde Department of Genetics, UMC Utrecht, The NetherlandsNetherlands Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? High-risk Populations Only SpeakerHila Milo Rasouly Hila.MiloRasouly@columbia.eduColumbia UniversityUnited States Hall A
12:45 p.m. 1:30 p.m.	Keys to success to be on top of what is published in nephrology (ISN-ACT) Spotlight SpeakerAndrea Viecelli University of QueenslandAustralia Spotlight SpeakerAugusto Cesar Soares dos Santos Junior Hospital das Clinicas, UFMG; Fac Ciências MedicasBrazil Spotlight SpeakerBrendan Smyth brendan.smyth@sydney.edu.auAustralia Spotlight SpeakerDavid Wheeler University College LondonUnited Kingdom Spotlight ChairpersonMeg Jardine NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Spotlight Stage 1 (exhibition hall)
3 p.m. 4 p.m.	Disparities in the Care of People Living with Kidney Failure in Latin America ChairpersonAdeera Levin University of British Columbia and Providence Health CareCanada ChairpersonAminu Bello University of AlbertaCanada Global Assessment of Kidney Care Capacity and Policy and Perspectives on Enhancing Global Kidney Care-Findings From the ISN-GKHA SpeakerAminu Bello University of AlbertaCanada State of CKD Care for Kidney Disease in Latin American Region SpeakerMagdalena Madero Chief of Nephrology, Instituto Nacional de CardiolMexico Variability in The Burden, Management and Outcomes of Kidney Failure Between Children and Adults in Latin America SpeakerMarina Wainstein Academia Nacional de Medicina de Buenos AiresArgentina Q and A Hall C1
4:30 p.m. 5:30 p.m.	Designing Smart Clinical Trials ChairpersonDebbie Gipson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States ChairpersonJonathan Barratt University of Leicester, Leicester, UKUnited Kingdom Patients Subphenotyping: The Example of Diabetic Kidney Disease SpeakerJohn Cijiang He cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease SpeakerLaura Mariani lmariani@umich.eduUniversity of MichiganUnited States Targeted Approaches in Clinical Trial Design SpeakerHiddo Lambers Heerspink H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

12:30 p.m. 1:30 p.m.	Rare and Orphan Diseases ChairpersonAli Gharavi ag2239@cumc.columbia.eduUnited States ChairpersonRoberta Fenoglio roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly ChairpersonVanina Vazquez azquezvanina64@gmail.comArgentina Alport Spectrum Disorders (Genetics) SpeakerMoumita Barua moumita.barua@uhn.caCanada Genetics of Nephrotic Syndrome SpeakerSimone Sanna-Cherchi ss2517@cumc.columbia.eduColumbia UniversityUnited States Lupus Nephritis Transcriptomics Across Time and Space SpeakerAna Malvar avmperrin@yahoo.com.arHospotal Fernandez, Organizacion Medica de InvestigacionArgentina Q and A Hall E

Time

Session

12:30 p.m.

1:30 p.m.

Rare and Orphan Diseases

ChairpersonAli Gharavi ag2239@cumc.columbia.eduUnited States

ChairpersonRoberta Fenoglio roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly

ChairpersonVanina Vazquez azquezvanina64@gmail.comArgentina

Alport Spectrum Disorders (Genetics)

SpeakerMoumita Barua moumita.barua@uhn.caCanada
Genetics of Nephrotic Syndrome

SpeakerSimone Sanna-Cherchi ss2517@cumc.columbia.eduColumbia UniversityUnited States
Lupus Nephritis Transcriptomics Across Time and Space

SpeakerAna Malvar avmperrin@yahoo.com.arHospotal Fernandez, Organizacion Medica de InvestigacionArgentina
Q and A

Hall E

Pre-Congress - Saturday April 13, 2024

Time	Session

4:30 p.m. 6 p.m.	WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina) ISN President's Address SpeakerMasaomi Nangaku Japan Tribute to Stewart Cameron Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair SpeakerGuillermo Rosa Diez guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina SpeakerJorge Rico jorgericof@yahoo.comColombia SpeakerMaria Papaginovic Leiva drapapaginovicleiva@gmail.comArgentina Welcome by Minister of Health for Buenos Aries Dr Fern Welcome by SPWG Chair Alessia Fornoni SpeakerAlessia Fornoni University of Miami United States The Origin of the Universe SpeakerDaniel De Florian deflo@unsam.edu.arUniversidad Nacional de San MartinArgentina Acceptance Speech: Hamburger Award SpeakerAdeera Levin University of British Columbia and Providence Health CareCanada Hall A
6:45 p.m. 7:15 p.m.	Building Renal Registry Capacity: Introducing ISN Spotlight SpeakerEtienne Ntabanganyimana Rwanda Spotlight SpeakerMaria Pippias University of BristolUnited Kingdom Spotlight ChairpersonFergus Caskey University of Bristol, UKUnited Kingdom Spotlight ChairpersonMaria Gonzalez registro@slanh.netSLANHUruguay Spotlight Stage 1 (exhibition hall)